| Stem definition | Drug id | CAS RN |
|---|---|---|
| systemic antifungal agents, miconazole derivatives | 2495 | 61318-90-9 |
None
None
| Date | Agency | Company | Orphan |
|---|---|---|---|
| Aug. 30, 1985 | FDA | RANBAXY |
None
None
None
None
| Source | Code | Description |
|---|---|---|
| ATC | D01AC09 | DERMATOLOGICALS ANTIFUNGALS FOR DERMATOLOGICAL USE ANTIFUNGALS FOR TOPICAL USE Imidazole and triazole derivatives |
| FDA CS | M0002083 | Azoles |
| FDA EPC | N0000175487 | Azole Antifungal |
| MeSH PA | D000890 | Anti-Infective Agents |
| MeSH PA | D000935 | Antifungal Agents |
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Tinea pedis | indication | 6020002 | DOID:12403 |
| Pityriasis versicolor | indication | 56454009 | DOID:9060 |
| Tinea corporis | indication | 84849002 | |
| Tinea cruris | indication | 399029005 |
None
None
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 5.02 | Basic |
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Alpha-2A adrenergic receptor | GPCR | Ki | 5.82 | DRUG MATRIX | |||||
| Cytochrome P450 3A4 | Enzyme | IC50 | 7.16 | DRUG MATRIX | |||||
| Sodium-dependent serotonin transporter | Transporter | Ki | 7.13 | DRUG MATRIX | |||||
| Sodium-dependent noradrenaline transporter | Transporter | Ki | 5.70 | DRUG MATRIX | |||||
| 5-hydroxytryptamine receptor 2A | GPCR | Ki | 5.95 | DRUG MATRIX | |||||
| 5-hydroxytryptamine receptor 2B | GPCR | Ki | 5.72 | DRUG MATRIX | |||||
| 5-hydroxytryptamine receptor 2C | GPCR | Ki | 5.84 | DRUG MATRIX | |||||
| Alpha-2B adrenergic receptor | GPCR | Ki | 5.79 | DRUG MATRIX | |||||
| D(3) dopamine receptor | GPCR | Ki | 5.98 | DRUG MATRIX | |||||
| Muscarinic acetylcholine receptor M1 | GPCR | Ki | 6.05 | DRUG MATRIX | |||||
| Muscarinic acetylcholine receptor M3 | GPCR | Ki | 6.14 | DRUG MATRIX | |||||
| Muscarinic acetylcholine receptor M5 | GPCR | Ki | 5.73 | DRUG MATRIX | |||||
| Alpha-2C adrenergic receptor | GPCR | Ki | 6.14 | DRUG MATRIX | |||||
| Sodium-dependent dopamine transporter | Transporter | Ki | 5.86 | DRUG MATRIX | |||||
| Cytochrome P450 2D6 | Enzyme | IC50 | 6.10 | DRUG MATRIX | |||||
| Adenosine receptor A3 | GPCR | Ki | 5.83 | DRUG MATRIX | |||||
| Cytochrome P450 2C9 | Enzyme | IC50 | 6.70 | DRUG MATRIX | |||||
| Cytochrome P450 1A2 | Enzyme | IC50 | 6.22 | DRUG MATRIX | |||||
| Cytochrome P450 2C19 | Enzyme | IC50 | 7.80 | DRUG MATRIX | |||||
| Alkaline phosphatase, tissue-nonspecific isozyme | Enzyme | EC50 | 4.22 | CHEMBL | |||||
| Tyrosine-protein kinase Fyn | Kinase | IC50 | 5.43 | DRUG MATRIX | |||||
| Thromboxane-A synthase | Enzyme | IC50 | 6.74 | DRUG MATRIX | |||||
| Bile acid receptor | Nuclear hormone receptor | IC50 | 5.16 | CHEMBL | |||||
| Indoleamine 2,3-dioxygenase 1 | Enzyme | IC50 | 5.19 | CHEMBL | |||||
| Substance-K receptor | GPCR | Ki | 5.78 | DRUG MATRIX | |||||
| Malate dehydrogenase cytoplasmic | Enzyme | IC50 | 4.70 | CHEMBL | |||||
| Muscarinic acetylcholine receptor M4 | GPCR | Ki | 6.26 | DRUG MATRIX | |||||
| Lanosterol 14-alpha demethylase | Enzyme | INHIBITOR | CHEMBL | CHEMBL | |||||
| Beta-lactamase | Enzyme | IC50 | 4.85 | CHEMBL | |||||
| Indoleamine 2,3-dioxygenase 2 | Enzyme | IC50 | 5 | CHEMBL | |||||
| Indoleamine 2,3-dioxygenase 1 | Enzyme | IC50 | 4.53 | CHEMBL |
| ID | Source |
|---|---|
| 4019938 | VUID |
| N0000148023 | NUI |
| D00886 | KEGG_DRUG |
| 61318-91-0 | SECONDARY_CAS_RN |
| 4019499 | VANDF |
| 4019938 | VANDF |
| C0075503 | UMLSCUI |
| CHEBI:9325 | CHEBI |
| CHEMBL1221 | ChEMBL_ID |
| CHEMBL1200348 | ChEMBL_ID |
| DB06820 | DRUGBANK_ID |
| C033308 | MESH_SUPPLEMENTAL_RECORD_UI |
| 5318 | PUBCHEM_CID |
| 4332 | INN_ID |
| 5D9HAA5Q5S | UNII |
| 37319 | RXNORM |
| 358697 | MMSL |
| 5521 | MMSL |
| 002933 | NDDF |
| 004964 | NDDF |
| 108920000 | SNOMEDCT_US |
| 108921001 | SNOMEDCT_US |
| 373448004 | SNOMEDCT_US |
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| Exelderm | HUMAN PRESCRIPTION DRUG LABEL | 1 | 69489-711 | CREAM | 10 mg | TOPICAL | NDA | 18 sections |
| Exelderm | HUMAN PRESCRIPTION DRUG LABEL | 1 | 69489-711 | CREAM | 10 mg | TOPICAL | NDA | 18 sections |
| Exelderm | HUMAN PRESCRIPTION DRUG LABEL | 1 | 69489-721 | SOLUTION | 10 mg | TOPICAL | NDA | 17 sections |
| Exelderm | HUMAN PRESCRIPTION DRUG LABEL | 1 | 69489-721 | SOLUTION | 10 mg | TOPICAL | NDA | 17 sections |
| Sulconazole Nitrate | HUMAN PRESCRIPTION DRUG LABEL | 1 | 72143-311 | CREAM | 10 mg | TOPICAL | NDA | 18 sections |
| Sulconazole Nitrate | HUMAN PRESCRIPTION DRUG LABEL | 1 | 72143-321 | SOLUTION | 10 mg | TOPICAL | NDA | 17 sections |